A federal Multi-District Litigation proceeding has been established in the San Francisco, California area that will control the vast multitude of Bextra and Celebrex cases filed in this country. This Multi-District Litigation (“MDL”) will act as a “litigation sponge” that will govern all federal filings in the Bextra/Celebrex litigation. Moreover, a majority of the state court filings in this area will eventually end up in this MDL. The MDL will obviously play a major role in the eventual outcome of this litigation.
Our firm was honored when Judge Charles R. Breyer, the federal judge overseeing this complex litigation, chose Paul Sizemore from our firm as one of the leaders of this national litigation. He was appointed to the Plaintiffs’ Screening Committee (PSC) by Judge Breyer. In this role, Paul will serve as the representative of literally thousands of lawyers and tens of thousands of injured and damaged folks from across the country. This position will require Paul to act in a leadership role in court before the judge and will allow our firm to help conduct the depositions of important Pfizer officers and employees.
We proudly accept this leadership position and promise both our clients and those lawyers whom we represent that we will work tirelessly to hold Pfizer responsible for the dangerous drugs they placed on the market. We look forward to our day in court so that we can prove to a jury the validity of our clients’ claims. We will not back down and neither will we be intimidated by powerful multi-billion dollar corporations. We will continue, as we have for the past 25 years, to fight for the rights and honor of our clients as well as for all victims of corporate wrongdoing and misconduct.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.